US FDA approves epinephrine autoinjector for infants and small children


eMediNexus    28 November 2017

The US Food and Drug Administration FDA has approved an epinephrine autoinjector 0.1mg designed specially to treat life threatening allergic reactions including anaphylaxis in infants and small children weighing 7.5 15 kg who are at risk for or have a history of serious allergic reactions. The new auto injector has a shorter needle length and lower dose of epinephrine than current FDA approved 0.15 mg and 0.3 mg epinephrine auto injectors.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.